Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19894 | 485 | 48.6 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
563 | 3 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
382 | 2 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
19894 | 1 | CHFR//RING FINGER PROTEIN 180//EPIGEN | 485 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHFR | authKW | 2417586 | 10% | 80% | 48 |
2 | RING FINGER PROTEIN 180 | authKW | 251834 | 1% | 100% | 4 |
3 | EPIGEN | address | 152516 | 4% | 12% | 21 |
4 | EPIGENETCANC | address | 141655 | 1% | 75% | 3 |
5 | EPIGENETIC FIELD DEFECT | authKW | 141655 | 1% | 75% | 3 |
6 | CANCER RELATED PATHWAY | authKW | 125917 | 0% | 100% | 2 |
7 | CHFR GENE | authKW | 125917 | 0% | 100% | 2 |
8 | BCL6B | authKW | 94435 | 1% | 50% | 3 |
9 | GASTRIC CANCER | authKW | 92403 | 29% | 1% | 142 |
10 | ABERRANT DNA METHYLATION | authKW | 87164 | 1% | 23% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4723 | 51% | 0% | 247 |
2 | Gastroenterology & Hepatology | 1115 | 15% | 0% | 73 |
3 | Pathology | 376 | 8% | 0% | 41 |
4 | Cell Biology | 253 | 13% | 0% | 65 |
5 | Genetics & Heredity | 219 | 10% | 0% | 49 |
6 | Biochemistry & Molecular Biology | 61 | 14% | 0% | 67 |
7 | Medicine, Research & Experimental | 44 | 5% | 0% | 23 |
8 | Medical Laboratory Technology | 34 | 2% | 0% | 8 |
9 | Microbiology | 19 | 4% | 0% | 20 |
10 | Biophysics | 8 | 3% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPIGEN | 152516 | 4% | 12% | 21 |
2 | EPIGENETCANC | 141655 | 1% | 75% | 3 |
3 | ADV CHRON DIS ACCDIS CITO | 83943 | 0% | 67% | 2 |
4 | MOL PATHOL BIOREN CEGIN | 83943 | 0% | 67% | 2 |
5 | TRANSLAT ONCOL CITO | 83943 | 0% | 67% | 2 |
6 | BOTUCATU BLOOD TRANSFUS | 62958 | 0% | 100% | 1 |
7 | BOTUCATU HEMO | 62958 | 0% | 100% | 1 |
8 | CANC CANC EPIGENET | 62958 | 0% | 100% | 1 |
9 | CANC DEV MINIMALLY INVAS TREATMENT | 62958 | 0% | 100% | 1 |
10 | DIGEST DIS MED THER EUT | 62958 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPIGENOMICS | 3397 | 1% | 1% | 5 |
2 | GASTRIC CANCER | 3307 | 1% | 1% | 6 |
3 | CANCER SCIENCE | 3003 | 3% | 0% | 13 |
4 | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY | 1570 | 0% | 1% | 2 |
5 | WORLD JOURNAL OF GASTROENTEROLOGY | 1362 | 4% | 0% | 19 |
6 | HELICOBACTER | 1207 | 1% | 0% | 5 |
7 | ONCOGENE | 984 | 4% | 0% | 17 |
8 | CANCER PREVENTION RESEARCH | 816 | 1% | 0% | 4 |
9 | INTERNATIONAL JOURNAL OF CANCER | 777 | 3% | 0% | 16 |
10 | ONCOLOGY REPORTS | 752 | 2% | 0% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHFR | 2417586 | 10% | 80% | 48 | Search CHFR | Search CHFR |
2 | RING FINGER PROTEIN 180 | 251834 | 1% | 100% | 4 | Search RING+FINGER+PROTEIN+180 | Search RING+FINGER+PROTEIN+180 |
3 | EPIGENETIC FIELD DEFECT | 141655 | 1% | 75% | 3 | Search EPIGENETIC+FIELD+DEFECT | Search EPIGENETIC+FIELD+DEFECT |
4 | CANCER RELATED PATHWAY | 125917 | 0% | 100% | 2 | Search CANCER+RELATED+PATHWAY | Search CANCER+RELATED+PATHWAY |
5 | CHFR GENE | 125917 | 0% | 100% | 2 | Search CHFR+GENE | Search CHFR+GENE |
6 | BCL6B | 94435 | 1% | 50% | 3 | Search BCL6B | Search BCL6B |
7 | GASTRIC CANCER | 92403 | 29% | 1% | 142 | Search GASTRIC+CANCER | Search GASTRIC+CANCER |
8 | ABERRANT DNA METHYLATION | 87164 | 1% | 23% | 6 | Search ABERRANT+DNA+METHYLATION | Search ABERRANT+DNA+METHYLATION |
9 | GASTRIC WASHES | 83943 | 0% | 67% | 2 | Search GASTRIC+WASHES | Search GASTRIC+WASHES |
10 | P41 ARC | 83943 | 0% | 67% | 2 | Search P41+ARC | Search P41+ARC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DERKS, S , CLEVEN, AHG , MELOTTE, V , SMITS, KM , BRANDES, JC , AZAD, N , VAN CRIEKINGE, W , DE BRUINE, AP , HERMAN, JG , VAN ENGELAND, M , (2014) EMERGING EVIDENCE FOR CHFR AS A CANCER BIOMARKER: FROM TUMOR BIOLOGY TO PRECISION MEDICINE.CANCER AND METASTASIS REVIEWS. VOL. 33. ISSUE 1. P. 161 -171 | 49 | 59% | 2 |
2 | SANBHNANI, S , YEONG, FM , (2012) CHFR: A KEY CHECKPOINT COMPONENT IMPLICATED IN A WIDE RANGE OF CANCERS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 69. ISSUE 10. P. 1669-1687 | 53 | 48% | 13 |
3 | PRIVETTE, LM , PETTY, EM , (2008) CHFR: A NOVEL MITOTIC CHECKPOINT PROTEIN AND REGULATOR OF TUMORIGENESIS.TRANSLATIONAL ONCOLOGY. VOL. 1. ISSUE 2. P. 57-64 | 41 | 65% | 15 |
4 | KUPCINSKAITE-NOREIKIENE, R , UGENSKIENE, R , NOREIKA, A , RUDZIANSKAS, V , GEDMINAITE, J , SKIECEVICIENE, J , JUOZAITYTE, E , (2016) GENE METHYLATION PROFILE OF GASTRIC CANCEROUS TISSUE ACCORDING TO TUMOR SITE IN THE STOMACH.BMC CANCER. VOL. 16. ISSUE . P. - | 24 | 67% | 1 |
5 | TAHARA, T , ARISAWA, T , (2015) DNA METHYLATION AS A MOLECULAR BIOMARKER IN GASTRIC CANCER.EPIGENOMICS. VOL. 7. ISSUE 3. P. 475 -486 | 32 | 37% | 11 |
6 | SAPARI, NS , LOH, M , VAITHILINGAM, A , SOONG, R , (2012) CLINICAL POTENTIAL OF DNA METHYLATION IN GASTRIC CANCER: A META-ANALYSIS.PLOS ONE. VOL. 7. ISSUE 4. P. - | 24 | 51% | 32 |
7 | SHIN, CM , KIM, N , JUNG, Y , PARK, JH , KANG, GH , KIM, JS , JUNG, HC , SONG, IS , (2010) ROLE OF HELICOBACTER PYLORI INFECTION IN ABERRANT DNA METHYLATION ALONG MULTISTEP GASTRIC CARCINOGENESIS.CANCER SCIENCE. VOL. 101. ISSUE 6. P. 1337 -1346 | 20 | 67% | 19 |
8 | SHI, H , WANG, XJ , WANG, JB , PAN, JD , LIU, JW , YE, B , (2016) ASSOCIATION BETWEEN CHFR GENE HYPERMETHYLATION AND GASTRIC CANCER RISK: A META-ANALYSIS.ONCOTARGETS AND THERAPY. VOL. 9. ISSUE . P. 7409 -7414 | 20 | 61% | 0 |
9 | XU, JN , LIU, ZH , SHEN, D , (2016) CLINICAL SIGNIFICANCE OF DAPK PROMOTER HYPERMETHYLATION IN GASTRIC CANCER: A META-ANALYSIS.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 9. ISSUE 5. P. 7883 -7895 | 18 | 62% | 1 |
10 | LI, YJ , LIANG, JR , HOU, P , (2015) HYPERMETHYLATION IN GASTRIC CANCER.CLINICA CHIMICA ACTA. VOL. 448. ISSUE . P. 124 -132 | 39 | 28% | 4 |
Classes with closest relation at Level 1 |